Latest filing published 27 May 2025 for Artivion, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Thomas F. Ackerman, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Artivion, Inc. and Charles River Laboratories International, Inc. In total, 7 filings cover trades dated from 10 February 2016 to 22 May 2025.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 27 May 2025, reports a share grant in Artivion, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations